Overview Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer Status: Recruiting Trial end date: 2033-01-31 Target enrollment: Participant gender: Summary This is phase 2 trial of neoadjuvant therapy and short-course radiotherapy in resectable rectal cancer. Phase: Phase 2 Details Lead Sponsor: Virginia Commonwealth University